UniPharma Co., Ltd. (6621)

Overview

UniPharma Co., Ltd., founded in 1998 and headquartered in Taipei, Taiwan, specializes in the distribution of pharmaceutical drugs, medical devices, and diagnostic tests across various medical fields. The company primarily focuses on areas such as oncology, gynecology, orthopedics, neurology, anesthesiology, and cardiology. UniPharma serves a wide range of healthcare facilities, including medical centers, regional hospitals, area hospitals, and clinics throughout Taiwan. Alongside its distribution activities, UniPharma is also actively involved in drug development, research and development, clinical trials, and marketing services, showcasing its comprehensive role within the healthcare and pharmaceutical industries.

Products and Services

• Adept reduction solution: A specialty pharmaceutical product designed to reduce the side effects associated with certain medical procedures.
• Bain, esmolol HCI, and naloxone anesthesia injections: A range of anesthesia injections that cater to different medical requirements, including general anesthesia and the reversal of opioid effects.
• Elisa DR-70 test: An in-vitro diagnostic test for the detection of tumors, leveraging the ELISA (Enzyme-Linked Immunosorbent Assay) technology for improved diagnostic accuracy.
• Fomeject antidote injection: A critical antidote injection used in emergency situations to counteract the effects of specific toxins.

In addition to these products, UniPharma Co., Ltd. offers extensive services in drug development, engaging in research and development, conducting clinical trials, and providing marketing and other business services to support the pharmaceutical and healthcare industries effectively. These initiatives underscore the company's commitment to advancing healthcare solutions and its active participation in the broader medical community.